Back to PRICE T ROWE ASSOCIATES INC /MD/ PRICE T ROWE ASSOCIATES INC /MD/

CGEMCGEM
21 quarters

Position history for PRICE T ROWE ASSOCIATES INC /MD/PRICE T ROWE ASSOCIATES INC /MD/'s holdings in CULLINAN THERAPEUTICS INC

PRICE T ROWE ASSOCIATES INC /MD/ holds 3.8M shares of CGEM (CULLINAN THERAPEUTICS INC), worth $69.7M as of 2026-Q2. The position was increased (+88.5% shares). CGEM represents 0.0% of PRICE T ROWE ASSOCIATES INC /MD/'s portfolio.

Current Value

$69.7M

Current Shares

3.8M

Total Value Change

+$39.5M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.8M
+88.5%
$69.7M0.0%$18.21
46
2026-Q1
Increased
2M
+4201.4%
$28.8M0.0%$15.73
46
2025-Q4
Increased
47,187
+9.1%
$489,0000.0%$9.92
26
2025-Q3
Increased
43,237
+18.7%
$257,0000.0%$5.97
19
2025-Q2
Increased
36,417
+14.8%
$275,0000.0%$7.76
18
2025-Q1
Increased
31,721
+7.5%
$241,0000.0%$8.02
17
2024-Q4
Increased
29,493
+15.3%
$360,0000.0%$12.20
19
2024-Q3
Increased
25,569
+22.9%
$429,0000.0%$17.19
20
2024-Q2
Decreased
20,799
-8.9%
$363,0000.0%$17.44
0
2024-Q1
Increased
22,842
+3.7%
$390,0000.0%$17.04
17
2023-Q4
Increased
22,022
+52.9%
$225,0000.0%$10.19
22
2023-Q3
Unchanged
14,402
0.0%
$131,0000.0%$9.05
0
2023-Q2
Increased
14,402
+2.6%
$155,0000.0%$11.00
16
2023-Q1
Decreased
14,037
-0.1%
$144,0000.0%$10.20
0
2022-Q4
Increased
14,052
+3.2%
$148,0000.0%$10.55
16
2022-Q3
Increased
13,617
+15.9%
$175,0000.0%$12.44
18
2022-Q2
Increased
11,746
+5.6%
$151,0000.0%$12.40
16
2022-Q1
Increased
11,127
+4.7%
$116,0000.0%$11.11
16
2021-Q4
New
10,627
-
$164,0000.0%$15.70
34
2021-Q2
Exited
0
-100.0%
$00.0%$26.01
0
2021-Q1
New
723,584
-
$30.2M0.0%$39.73
40

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used